the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma

NCT01717066 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Stage I Hepatocellular Carcinoma
Stage II Hepatocellular Carcinoma

Interventions

DRUG: the ginsenoside Rg3
DRUG: Placebo

Sponsor

ShenFeng

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]